Daptomycin In Vitro Activity against Methicillin-Resistant Staphylococcus aureus Is Enhanced by d-Cycloserine in a Mechanism Associated with a Decrease in Cell Surface Charge

Por Gasch, O., Pillai, S. K., Dakos, J., Miyakis, S., Moellering, R. C., Eliopoulos, G. M.
Publicado em 2013

Fosfomycin plus β-Lactams as Synergistic Bactericidal Combinations for Experimental Endocarditis Due to Methicillin-Resistant and Glycopeptide-Intermediate Staphylococcus aureus

Por del Río, A., García-de-la-Mària, C., Entenza, J. M., Gasch, O., Armero, Y., Soy, D., Mestres, C. A., Pericás, J. M., Falces, C., Ninot, S., Almela, M., Cervera, C., Gatell, J. M., Moreno, A., Moreillon, P., Marco, F., Miró, J. M.
Publicado no Antimicrob Agents Chemother (2015)

Daptomycin plus fosfomycin versus daptomycin monotherapy in treating MRSA: protocol of a multicentre, randomised, phase III trial

Por Shaw, E, Miró, J M, Puig-Asensio, M, Pigrau, C, Barcenilla, F, Murillas, J, Garcia-Pardo, G, Espejo, E, Padilla, B, Garcia-Reyne, A, Pasquau, J, Rodriguez-Baño, J, López-Contreras, J, Montero, M, de la Calle, C, Pintado, V, Calbo, E, Gasch, O, Montejo, M, Salavert, M, Garcia-Pais, M J, Carratalà, J, Pujol, M
Publicado no BMJ Open (2015)